|
🐜
|
Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer
8 auth.
O. Slabý,
M. Svoboda,
P. Fabián,
T. Šmerdová,
D. Knoflíčková,
M. Bednaříková,
...
R. Nenutil,
R. Vyzula
|
9 |
2008 |
9
🐜
|
|
🐬
|
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
O. Slabý,
M. Svoboda,
J. Michálek,
R. Vyzula
|
8 |
2009 |
8
🐬
|
|
🐬
|
Novel classes of non-coding RNAs and cancer
J. Šána,
Petra Faltejsková,
M. Svoboda,
O. Slabý
|
8 |
2012 |
8
🐬
|
|
🐜
|
Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
9 auth.
M. Rédová,
A. Poprach,
J. Nekvindová,
Robert Iliev,
L. Radová,
R. Lakomý,
...
M. Svoboda,
R. Vyzula,
O. Slabý
|
8 |
2012 |
8
🐜
|
|
🐜
|
MiR‐195, miR‐196b, miR‐181c, miR‐21 expression levels and O‐6‐methylguanine‐DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
13 auth.
R. Lakomý,
J. Šána,
Simona Hankeová,
P. Fadrus,
L. Křen,
E. Lžičařová,
M. Svoboda,
H. Doleželová,
M. Smrcka,
R. Vyzula,
...
J. Michálek,
M. Hajdůch,
O. Slabý
|
7 |
2011 |
7
🐜
|
|
🐜
|
Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
7 auth.
N. Thorenoor,
Petra Faltejskova-Vychytilova,
Sonja Hombach,
J. Mlčochová,
M. Kretz,
M. Svoboda,
...
O. Slabý
|
7 |
2015 |
7
🐜
|
|
🐜
|
Identification and functional screening of microRNAs highly deregulated in colorectal cancer
12 auth.
Petra Faltejsková,
M. Svoboda,
K. Šrůtová,
J. Mlčochová,
A. Besse,
J. Nekvindová,
...
L. Radová,
P. Fabián,
K. Slabá,
I. Kiss,
R. Vyzula,
O. Slabý
|
7 |
2012 |
7
🐜
|
|
🐜
|
Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.
13 auth.
P. Vychytilová-Faltejsková,
L. Radová,
M. Šachlová,
Zdeňka Kosařová,
K. Slabá,
P. Fabián,
T. Grolich,
V. Procházka,
Z. Kala,
M. Svoboda,
...
I. Kiss,
R. Vyzula,
O. Slabý
|
7 |
2016 |
7
🐜
|
|
🐜
|
MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients.
13 auth.
O. Slabý,
Roman Lakomý,
P. Fadrus,
Roman Hrstka,
L. Křen,
E. Lžičařová,
M. Smrčka,
M. Svoboda,
H. Doležalová,
Jana Nováková,
...
D. Valík,
R. Vyzula,
Jaroslav Michálek
|
7 |
2010 |
7
🐜
|
|
🐬
|
Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer
O. Slabý,
J. Bienertová-Vašků,
M. Svoboda,
R. Vyzula
|
7 |
2011 |
7
🐬
|
|
🦁
|
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
9 auth.
M. Svoboda,
J. Šána,
P. Fabián,
I. Kocáková,
J. Gombošová,
J. Nekvindová,
...
L. Radová,
R. Vyzula,
O. Slabý
|
6 |
2012 |
6
🦁
|
